We are live on
!
Find out more
Verrica Pharmaceuticals
VRCA
VRCA
49 hedge funds and large institutions have $29.9M invested in Verrica Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more capital invested
Capital invested by funds: $21.8M → $29.9M (+$8.16M)
0% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 15
1.62% less ownership
Funds ownership: 4.12% → 2.49% (-1.6%)
14% less funds holding
Funds holding: 57 → 49 (-8)
37% less call options, than puts
Call options by funds: $86K | Put options by funds: $137K
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Holders
49
Holders Change
-8
Holders Change %
-14.04%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
15
Reduced
15
Closed
14
Calls
$86K
Puts
$137K
Net Calls
-$51K
Net Calls Change
-$47K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$625K |
| 2 |
BlackRock
New York
|
+$232K |
| 3 |
MML Investors Services
Springfield,
Massachusetts
|
+$158K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$109K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$99.7K |
Top Sellers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.03M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$919K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$864K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$556K |
| 5 |
Millennium Management
New York
|
-$204K |
